Tilray Brands Inc. (TLRY)
NASDAQ: TLRYHealth Care Medicinal Chemicals and Botanical Products USD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
TLRY stock chart
Technical analysisKey statistics
All statistics- Market cap
- $279.32M
- Forward P/E
- 13.30
- EPS (TTM)
- -$1.41
- Dividend yield
- None
- 52-week range
- 1.87 – 15.70
- Day range
- 1.87 – 2.08
- Volume / Avg
- 7.87M / 4.35M
- Beta
- —
- Shares outstanding
- 147.79M
52-week range
TLRY stock today
Tilray Brands (TLRY) closed at $1.89 on Nov 20, down 8.70% (-$0.18), versus the S&P 500's 3.70% decline. Shares are 88.0% below their 52-week high of $15.70, set on Dec 18, 2025 and 1.1% above the 52-week low of $1.87, near the bottom of the past year's range. TLRY is down 79.1% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 79.2%.
Tilray Brands has posted a net loss over the last twelve months (EPS of -$1.41), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Tilray Brands
Company profileTilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally. The company operates through four segments: Beverage, Cannabis, Distribution, and Wellness. It also offers medical and adult-use cannabis products; resells and distributes pharmaceutical and wellness products; and produces, markets, and sells beverage products, and hemp-based food products.
- Sector
- Health Care
- Industry
- Medicinal Chemicals and Botanical Products
- CEO
- Mr. Irwin David Simon
- Headquarters
- Leamington, ON
- Employees
- 3,595
- IPO year
- 2018
- Website
- tilray.com
Financial highlights
Full financialsIn fiscal 2026, Tilray Brands generated $915.5 million in revenue, up 11.5% from fiscal 2025, its 3rd consecutive year of revenue growth. Tilray Brands reported a net loss of $121.4 million, compared with a loss of $2.19 billion a year earlier. Gross margin was 28.4% (down from 29.3%) and operating margin -6.9%.
| Fiscal year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Revenue | $915.45M | $821.31M | $788.94M | $627.12M | $628.37M |
| Growth | +11.46% | +4.10% | +25.80% | -0.20% | +22.47% |
| Net income | $-121.40M | $-2.19B | $-244.98M | $-1.45B | $-476.80M |
| EPS (diluted) | $-1.09 | $-24.56 | $-3.30 | $-2.35 | $-0.99 |
Analyst forecast
ForecastConsensus (10 analysts)
none
Avg. price target
$5.72+202.65%
- Strong buy 0
- Buy 3
- Hold 7
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Aug/2026)
- Oct 8, 2026
- EPS actual vs est.
- $-0.32 vs $-0.19
- Surprise
- -68.42%
TLRY news
All TLRY news- Is Tilray a Buy at Its Record Low, or Is It a Value Trap?NasdaqTLRY, MOG.B
- Tilray Has More Cash Than Debt and 71% Growth in Europe. Is This Cannabis Stock a Buy?NasdaqTLRY, UHAL.B
- Tilray Brands, Inc. Stockholders Re-Elect Class II Directors and Reject Board Declassification Proposal at 2026 Annual MeetingNasdaqTLRY, MKC.V
- Why Didn't Tilray Brands Make a Bid for Aurora Cannabis?NasdaqTLRY, ACB, CFR
- 10 Barrel Brewing, Widmer Brothers and Hop Valley Named Official Craft Beer Partners of the Portland Trail BlazersGlobeNewswire
- Whiskey You Won't Find on Shelves: Breckenridge Distillery Launches the 2 Mile High Whiskey ClubGlobeNewswire
- Does Marijuana Rescheduling Really Help Tilray's Stock?Nasdaq
- Tilray Raises Its Guidance for the Year. Is the Stock Finally Headed on the Right Track?NasdaqTLRY, MOG.A
Tilray Brands peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ACBAurora Cannabis Inc. | 4.16 | -2.35% | $273.50M | vs TLRY |
| SNDLSNDL Inc. | 1.17 | -5.65% | $285.20M | vs TLRY |
| USNAUSANA Health Sciences Inc. | 12.94 | -1.67% | $239.24M | vs TLRY |
| MDWDMediWound Ltd. | 13.59 | +0.37% | $195.56M | vs TLRY |
| CGCCanopy Growth Corporation | 0.427 | -9.97% | $191.99M | vs TLRY |
| NAGENiagen Bioscience Inc. | 1.84 | -1.60% | $145.72M | vs TLRY |
| GLASGlass House Brands Inc. Subordinate Voting Shares | 1.18 | -2.48% | $118.11M | vs TLRY |
| ISPRIspire Technology Inc. | 1.23 | -3.15% | $71.05M | vs TLRY |
Indexes, lists and sector
Tilray Brands stock FAQ
What is Tilray Brands's stock price today?
TLRY last traded at $1.89 as of Nov 20, 4:00 PM EST, down 8.70% on the day. Prices are delayed at least 15 minutes.
Does Tilray Brands pay a dividend?
No. Tilray Brands does not currently pay a regular cash dividend.
Who is Tilray Brands's CEO?
Mr. Irwin David Simon is the chief executive officer of Tilray Brands Inc., which has about 3,595 employees.
Has TLRY ever split its stock?
Yes. The most recent TLRY stock split was a 1-for-10 split on Dec 2, 2025.
What is the TLRY 52-week high?
The 52-week high for TLRY is $15.70 and the 52-week low is $1.87. The stock is currently 88.0% below its high.